Super-Resolution Ultrasound Radiomics Can Predict the Upstaging of Ductal Carcinoma In Situ

超分辨率超声放射组学可预测导管原位癌的分期升级。

阅读:1

Abstract

INTRODUCTION: Preoperatively distinguishing pure ductal carcinoma in situ (DCIS) from upstaged DCIS is important for deciding optimal surgical strategies. However, it is hard to preoperatively predict the upstaging of biopsy-proven DCIS. This study aims to develop an effective radiomics model for predicting the upstaging of DCIS based on super-resolution (SR) ultrasound images. METHODS: In this multicentre retrospective study, patients with biopsy-proven DCIS who underwent ultrasound examination were included. A super-resolution reconstruction algorithm was used to enhance the resolution of original high resolution (HR) ultrasound images and obtain SR images. Pyradiomics was used for feature extraction. The selected HR radiomics features and SR radiomics features were combined with clinical features to construct the HR fusion model and SR fusion model, respectively. The area under the receiver operating characteristic curve (AUC) of the models and radiologists was analyzed and compared by the Delong test. RESULTS: A total of 681 women (median age, 47 years; interquartile range, 42-54) with 681 biopsy-proven DCIS lesions were included, with 422 lesions in the training set, 106 lesions in the validation set, and 153 lesions in the external test set. The SR Fusion model achieved an AUC of 0.819 (0.732-0.887) in the validation set and 0.800 (95% CI 0.728-0.860) in the external test set. It outperformed the radiologists (AUC = 0.603-0.627; p < 0.001) in the validation set. Additionally, it surpassed the clinical model (AUC = 0.682, 95% CI 0.602-0.755; p = 0.02) and the HR Fusion model (AUC = 0.724, 95% CI 0.646-0.793; p = 0.03) in the external test set. CONCLUSION: The SR Fusion model integrating SR features and clinical features can effectively predict the upstaging of DCIS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。